These results further demonstrate that NAT1 inhibits the EMT and glycolysis ability of colorectal cancer cells through the PI3K/AKT/mTOR signaling pathway, thereby suppressing the proliferation and metastasis of colorectal cancer. This evidence concerns the gene MTOR and colorectal cancer.